Crescent Capital BDC’s (CCAP) “Market Perform” Rating Reaffirmed at Oppenheimer

Oppenheimer reiterated their market perform rating on shares of Crescent Capital BDC (NASDAQ:CCAPFree Report) in a research report released on Friday, MarketBeat Ratings reports.

CCAP has been the subject of several other research reports. B. Riley Financial reissued a “neutral” rating on shares of Crescent Capital BDC in a research note on Friday. Wells Fargo & Company dropped their price objective on shares of Crescent Capital BDC from $13.00 to $12.00 and set an “equal weight” rating for the company in a research note on Friday. Keefe, Bruyette & Woods dropped their price objective on shares of Crescent Capital BDC from $15.50 to $15.00 and set an “outperform” rating for the company in a research note on Thursday, April 16th. Finally, Zacks Research raised shares of Crescent Capital BDC from a “strong sell” rating to a “hold” rating in a research note on Tuesday, February 10th. Two research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. According to MarketBeat.com, Crescent Capital BDC currently has an average rating of “Hold” and an average price target of $14.30.

Check Out Our Latest Analysis on CCAP

Crescent Capital BDC Price Performance

Shares of NASDAQ:CCAP opened at $11.13 on Friday. The company has a market cap of $410.14 million, a price-to-earnings ratio of 27.15 and a beta of 0.59. The company has a debt-to-equity ratio of 1.35, a current ratio of 1.53 and a quick ratio of 1.22. The firm has a 50 day simple moving average of $12.93 and a 200 day simple moving average of $13.76. Crescent Capital BDC has a one year low of $11.03 and a one year high of $16.03.

Crescent Capital BDC (NASDAQ:CCAPGet Free Report) last issued its quarterly earnings data on Wednesday, May 13th. The company reported $0.42 EPS for the quarter, beating the consensus estimate of $0.41 by $0.01. The business had revenue of ($6.84) million during the quarter, compared to the consensus estimate of $39.58 million. Crescent Capital BDC had a net margin of 9.26% and a return on equity of 9.34%. Research analysts predict that Crescent Capital BDC will post 1.63 earnings per share for the current fiscal year.

Crescent Capital BDC Dividend Announcement

The firm also recently declared a special dividend, which will be paid on Tuesday, December 15th. Stockholders of record on Monday, November 30th will be paid a dividend of $0.03 per share. The ex-dividend date of this dividend is Monday, November 30th. This represents a dividend yield of 107.0%. Crescent Capital BDC’s dividend payout ratio (DPR) is presently 409.76%.

Hedge Funds Weigh In On Crescent Capital BDC

Several large investors have recently modified their holdings of CCAP. Royal Bank of Canada raised its stake in shares of Crescent Capital BDC by 3.6% during the first quarter. Royal Bank of Canada now owns 61,707 shares of the company’s stock valued at $1,056,000 after acquiring an additional 2,128 shares during the last quarter. XTX Topco Ltd bought a new position in Crescent Capital BDC during the second quarter worth $165,000. Quantbot Technologies LP bought a new position in Crescent Capital BDC during the second quarter worth $219,000. Invesco Ltd. raised its stake in Crescent Capital BDC by 31.4% during the second quarter. Invesco Ltd. now owns 38,377 shares of the company’s stock worth $541,000 after buying an additional 9,180 shares during the last quarter. Finally, Jump Financial LLC bought a new position in Crescent Capital BDC during the second quarter worth $286,000. Institutional investors own 49.46% of the company’s stock.

Crescent Capital BDC News Roundup

Here are the key news stories impacting Crescent Capital BDC this week:

About Crescent Capital BDC

(Get Free Report)

Crescent Capital BDC, Inc is a closed-end, externally managed business development company that provides flexible financing solutions to middle market companies in the United States. Trading on the Nasdaq under the ticker CCAP, the firm offers investors exposure to a diversified portfolio of debt and equity instruments, targeting businesses with attractive risk-adjusted return profiles. Its primary objective is to generate current income through interest payments and potential capital appreciation via selective equity co-investments.

The company’s investment strategy emphasizes senior secured loans, unsecured second-lien loans, mezzanine debt, as well as preferred and common equity co-investments.

See Also

Analyst Recommendations for Crescent Capital BDC (NASDAQ:CCAP)

Receive News & Ratings for Crescent Capital BDC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crescent Capital BDC and related companies with MarketBeat.com's FREE daily email newsletter.